Report cover image

Tissium SA - Product Pipeline Analysis, 2025 Update

Publisher GlobalData
Published Sep 22, 2025
Length 31 Pages
SKU # GBDT20417163

Description

Summary

Tissium SA (Tissium), formerly Gecko Biomedical, is a life science company that provides polymer solutions for tissue reconstruction. The company offers products such as coaptium for the treatment of peripheral nerve; Eclipsium for gastrointestinal diseases; and Setalium which treats cardiovascular diseases. It designs surgical scaffolds using 3D printing technology for peripheral nerve repair, formulate drug-eluting solutions for tissue repair. The company operates through laboratory and factory office located in France. It operates in France and the US. Tissium is headquartered in Paris, Ile-de-France, France.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Tissium SA
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company

Table of Contents

31 Pages
Tissium SA Company Overview
Tissium SA Company Snapshot
Tissium SA Pipeline Products and Ongoing Clinical Trials Overview
Tissium SA – Pipeline Analysis Overview
Tissium SA - Key Facts
Tissium SA - Major Products and Services
Tissium SA Pipeline Products by Development Stage
Tissium SA Ongoing Clinical Trials by Trial Status
Tissium SA Pipeline Products Overview
COAPTIUM Connect with TISSIUM LIGHT
COAPTIUM Connect with TISSIUM LIGHT Product Overview
Drug-Eluting Adhesive - Chronic Rhinosinusitis
Drug-Eluting Adhesive - Chronic Rhinosinusitis Product Overview
GB-02 - Tissue Reconstruction
GB-02 - Tissue Reconstruction Product Overview
GB-04 - Sutureless Closure
GB-04 - Sutureless Closure Product Overview
Hernia Repair Adhesive
Hernia Repair Adhesive Product Overview
Hernia Repair Adhesive Clinical Trial
Sutureless Nerve Coaptation Device
Sutureless Nerve Coaptation Device Product Overview
Tissium SA - Key Competitors
Tissium SA - Key Employees
Tissium SA - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Tissium SA, Recent Developments
Jul 03, 2025: Tissium Receives DeNovo Clearance for COAPTIUM Connect with TISSIUM LIGHT
Jun 24, 2025: Tissium Receives FDA de Novo Authorization for Coaptium Connect in Atraumatic Sutureless Peripheral Nerve Repair
Jun 24, 2025: TISSIUM wins FDA approval for sutureless nerve repair platform
Apr 02, 2025: TISSIUM Announces Clinical Results of COAPTIUM CONNECT System for Atraumatic Sutureless Nerve Repair
Sep 12, 2023: First Patients Treated with Tissium’s Atraumatic Hernia Repair System
Mar 30, 2023: First patients treated with TISSIUM’s at raumatic sutureless nerve coaptation system
Feb 02, 2022: 5 Sofinnova Partners Portfolio Companies Selected to French Tech 120
Oct 06, 2021: TISSIUM to present study results at the Hernia 2021 European Hernia Society – American Hernia Society Joint Congress
Sep 24, 2021: TISSIUM to Present Study Results at the 76th Annual Meeting of the American Society for Surgery of the Hand
Nov 17, 2020: TISSIUM receives FDA investigational device exemption for vascular sealant
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Tissium SA Pipeline Products and Ongoing Clinical Trials Overview
Tissium SA Pipeline Products by Equipment Type
Tissium SA Pipeline Products by Indication
Tissium SA Ongoing Clinical Trials by Trial Status
Tissium SA, Key Facts
Tissium SA, Major Products and Services
Tissium SA Number of Pipeline Products by Development Stage
Tissium SA Pipeline Products Summary by Development Stage
Tissium SA Ongoing Clinical Trials by Trial Status
Tissium SA Ongoing Clinical Trials Summary
COAPTIUM Connect with TISSIUM LIGHT - Product Status
COAPTIUM Connect with TISSIUM LIGHT - Product Description
Drug-Eluting Adhesive - Chronic Rhinosinusitis - Product Status
Drug-Eluting Adhesive - Chronic Rhinosinusitis - Product Description
GB-02 - Tissue Reconstruction - Product Status
GB-02 - Tissue Reconstruction - Product Description
GB-04 - Sutureless Closure - Product Status
GB-04 - Sutureless Closure - Product Description
Hernia Repair Adhesive - Product Status
Hernia Repair Adhesive - Product Description
Hernia Repair Adhesive - ALPHA: A Pilot Study to Evaluate the Initial Safety and Performance of the TISSIUM Atraumatic Hernia Repair System (TAHRS) for Laparoscopic Hernia Repair
Sutureless Nerve Coaptation Device - Product Status
Sutureless Nerve Coaptation Device - Product Description
Tissium SA, Key Employees
Tissium SA, Other Locations
Glossary
List of Figures
Tissium SA Pipeline Products by Equipment Type
Tissium SA Pipeline Products by Development Stage
Tissium SA Ongoing Clinical Trials by Trial Status

Search Inside Report

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us